puromycin aminonucleoside has been researched along with cyclosporine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, H; Kokui, K; Nakamura, H; Yoshikawa, N | 1 |
| Chen, SM; Chiang, H; Liu, HC; Wang, JS; Yang, AH; Young, TK | 1 |
| Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y | 1 |
| Bustos, C; Egido, J; González-Cuadrado, S; Guijarro, C; Ortiz, A; Plaza, JJ; Ruiz-Ortega, M | 1 |
| Krivoshchapov, LG; Pal'tseva, EM | 1 |
| Choi, KH; Ha, SK; Han, DS; Kang, SW; Kim, BS; Lee, HY; Park, HC | 1 |
| Castañeda-Hernández, G; Medeiros, M; Muñoz-Arizpe, R; Pedraza-Chaverri, J; Pérez-Urizar, J | 1 |
| Fujita, K; Fujita, T; Kamata, Y; Kumagai, Y; Majima, M; Ohtani, Y; Yasuda, S | 1 |
| Artero, M; Carraro, M; Di Maso, V; Pascolo, L; Rastaldi, MP; Stebel, M; Tiribelli, C; Trevisan, E; Zennaro, C | 1 |
| Ding, F; Ding, J; Li, B; Li, X; Wang, S | 1 |
| Bi, Y; Chen, J; Feng, S; Huang, X; Jiang, H; Lan, HY; Li, M; Li, X; Lin, C; Lin, W; Shen, J; Shen, X; Wang, H; Wang, L; Wang, Y; Weng, C; Xie, Z; Ying, M; Zhao, J; Zhou, J; Zhou, Q; Zhu, T | 1 |
11 other study(ies) available for puromycin aminonucleoside and cyclosporine
| Article | Year |
|---|---|
Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
Topics: Animals; Anions; Basement Membrane; Creatine; Cyclosporine; Kidney; Kidney Glomerulus; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1992 |
Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Topics: Animals; Catalase; Cyclosporine; Glutathione; Kidney Glomerulus; Male; Malondialdehyde; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1993 |
The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Anticholesteremic Agents; Azathioprine; CD4-Positive T-Lymphocytes; Cholestyramine Resin; Clofibrate; Cyclosporine; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Glomerulus; Leukocytes, Mononuclear; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-2 | 1996 |
Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis.
Topics: Animals; Chemokine CCL2; Chemokine CXCL10; Chemokines; Chemokines, CXC; Connective Tissue; Connective Tissue Cells; Cyclosporine; Cytokines; Fibroblasts; Fibrosis; Kidney; Nephritis, Interstitial; Puromycin Aminonucleoside; Rats; RNA, Messenger; Up-Regulation | 1996 |
[Effects of immunosuppressor and cytostatic agents on the extracellular matrix production during experimental neuropathies].
Topics: Animals; Antineoplastic Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Extracellular Matrix; Glomerulonephritis; Immunosuppressive Agents; Methylprednisolone; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1998 |
Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Topics: Animals; Antimetabolites, Antineoplastic; Cyclosporine; Immunosuppressive Agents; Kidney Glomerulus; Male; Membrane Proteins; Nephrosis; Phosphoproteins; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2005 |
Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
Topics: Animals; Area Under Curve; Biological Availability; Cholesterol; Cyclosporine; Disease Models, Animal; Half-Life; Hypercholesterolemia; Hypertriglyceridemia; Hypoalbuminemia; Immunosuppressive Agents; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2007 |
Contribution of down-regulation of intestinal and hepatic cytochrome P450 3A to increased absorption of cyclosporine A in a rat nephrosis model.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Disease Models, Animal; Down-Regulation; Interleukin-6; Intestines; Liver; Male; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2008 |
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Adhesion; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Cyclosporine; Cytoprotection; Gene Expression; Humans; Kidney Glomerulus; Male; Organic Anion Transporters; Penicillin G; Podocytes; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Serum Albumin | 2013 |
Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.
Topics: Actins; Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Gene Expression Regulation; Humans; Kidney Diseases; Mice; Microfilament Proteins; Phosphorylation; Podocytes; Puromycin Aminonucleoside; Visual Cortex; Wiskott-Aldrich Syndrome Protein Family | 2015 |
Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
Topics: Animals; Apoptosis; Calcineurin Inhibitors; Cell Line; Cyclosporine; Male; MAP Kinase Signaling System; Mice; Nephrosis, Lipoid; Podocytes; Proteinuria; Puromycin Aminonucleoside; Rats, Sprague-Dawley; Tacrolimus | 2016 |